Widmer N. | Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
スポンサーリンク
概要
- WIDMER N.の詳細を見る
- 同名の論文著者
- Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier Uの論文著者
関連著者
-
Widmer N.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Rochat B.
Plate-forme De Spectrometrie De Masse Department De Recherche Centre Hospitalier Universitaire Vaudo
-
Leyvraz S.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Duchosal M.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Widmer N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
BEGUIN A.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
ROCHAT B.
Plate-forme de Spectrometrie de Masse, Department de Recherche, Centre Hospitalier Universitaire Vau
-
BUCLIN T.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
KOVACSOVICS T.
Service d'Hematologie, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
DUCHOSAL M.
Service d'Hematologie, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
LEYVRAZ S.
Centre coordonne d'Oncologie Ambulatoire, Centre Hospitalier Universitaire Vaudois
-
ROSSELET A.
Service d'Hematologie, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
BIOLLAZ J.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
DECOSTERD L.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
Buclin T.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Beguin A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Rosselet A.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Kovacsovics T.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Biollaz J.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Zaman K.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Rochat B.
Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
-
Leyvraz S.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
HAOUALA A.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
ZANOLARI B.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
MONTEMURRO M.
Multidisciplinary Oncology Centre, Centre Hospitalier Universitaire Vaudois and University of Lausan
-
RIS H.
Divisions of Thoracic and Vascular Surgery, Centre Hospitalier Universitaire Vaudois and University
-
Ris H.
Divisions Of Thoracic And Vascular Surgery Centre Hospitalier Universitaire Vaudois And University O
-
Haouala A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Montemurro M.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Zanolari B.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Zanolari B.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
著作論文
- Determination of imatinib (Gleevec^【○!R】) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry